Ellingson, Mallory K.
Oliveira, Carlos R.
Sheth, Sangini S.
Sullivan, Erin L.
Torres, Ashlynn
Shapiro, Eugene D.
Niccolai, Linda M.
Article History
Received: 10 November 2020
Accepted: 14 June 2021
First Online: 1 July 2021
Declarations
:
: This study was approved by the Yale University Institutional Review Board. All methods were performed in accordance with the relevant guidelines and regulations. All participants provided written informed consent upon enrollment.
: N/A
: Dr. Sheth receives 9vHPV (Gardasil 9) vaccine through the Merck Investigator Studies Program as a “drug only” research award and has served as a consultant for Merck. Dr. Niccolai serves as Scientific Advisor to Merck. Drs. Oliveira and Shapiro and Mss. Sullivan, Torres and Ellingson declare that they have no competing interests.